Within-person variation in fasting blood glucose is correlated to incidence of hypoglyacernia in people with Type 1 diabetes treated with insulin detemir and NPH insulin

被引：0

作者：

Heller, S

Kim, H

Draeger, E

机构：

[1] Univ Sheffield, Ctr Clin Sci, Sheffield S10 2TN, S Yorkshire, England

[2] Novo Nordisk AS, Clin Stat, Gladsaxe, Denmark

[3] CDC Europe Med Affairs NNRE, Novo Nordisk Reg Europe, Zurich, Switzerland

来源：

DIABETOLOGIA | 2004年 / 47卷

关键词：

D O I：

暂无

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

841

引用

页码：A303 / A303

页数：1

共 50 条

[1] Within-person variation in fasting blood glucose is correlated to incidence of hypoglycernia in people with type 1 diabetes treated with insulin detemir and NPH
Heller, S
Olsen, KJ
Draeger, E
[J]. DIABETES, 2004, 53 : A486 - A487
[2] Lower within-subject variability of insulin detemir in comparison to NPH insulin and insulin glargine in people with type 1 diabetes
Heise, T
Nosek, L
Ronn, BB
Endahl, L
Heinemann, L
Kapitza, C
Draeger, E
[J]. DIABETES, 2004, 53 (06) : 1614 - 1620
[3] Lower within-subject variability of fasting blood glucose and reduced weight gain with insulin detemir compared to NPH insulin in patients with type 2 diabetes
Haak, T
Tiengo, A
Draeger, E
Suntum, M
Waldhäusl, W
[J]. DIABETES OBESITY & METABOLISM, 2005, 7 (01): : 56 - 64
[4] Insulin detemir is associated with lower risk of hypoglycemia compared to NPH insulin in people with Type 1 diabetes
Kolendorf, K
Prasek, M
Santeusanio, F
Philotheou, A
Gall, MA
Heller, S
[J]. DIABETOLOGIA, 2004, 47 : A329 - A329
[5] Insulin detemir is associated with lower risk of hypoglycemia compared to NPH insulin in people with type 1 diabetes
Kolendorf, K
Pavlic-Renar, I
San-Teusanio, F
Philotheou, A
Gall, MA
Heller, S
[J]. DIABETES, 2004, 53 : A130 - A131
[6] Fasting blood glucose for insulin adjustment with insulin glargine or NPH insulin combined with sulphonylurea in Type 2 diabetes
Haupt, A
Eckert, H
Schweitzer, MA
Peiker, J
Häring, HU
Fritsche, A
[J]. DIABETOLOGIA, 2004, 47 : A269 - A269
[7] Insulin detemir compared with NPH insulin in children and adolescents with Type 1 diabetes
Robertson, K. J.
Schoenle, E.
Gucev, Z.
Mordhorst, L.
Gall, M. -A.
Ludvigsson, J.
[J]. DIABETIC MEDICINE, 2007, 24 (01) : 27 - 34
[8] Lower within-subject variability of insulin detemir in comparison to NPH insulin and insulin glargine in subjects with type 1 diabetes
Heise, T
Nosek, L
Draeger, E
Stender, A
Ronn, BB
Kapitza, C
Heinemann, L
[J]. DIABETES, 2003, 52 : A121 - A121
[9] Less glucose variability with insulin detemir compared to NPH insulin in subjects with type 1 diabetes undergoing continuous glucose monitoring
Jones, David R.
Clauson, Per
Ong, Stephanie
Mathieu, Chantal
[J]. DIABETES, 2006, 55 : A118 - A118
[10] Plasma glucose profiles in patients with type 1 diabetes treated with insulin glargine or NPH insulin
Garg, SK
Chase, HP
Marshall, G
[J]. DIABETES, 2001, 50 : A435 - A436

← 1 2 3 4 5 →